Biontech US INC.
Immunotherapy research and development
Based in MA
🤖
AI Overview
With $660K in lobbying spend across 8 quarterly filings, Biontech US INC is an active lobbying client. Their lobbying covers 3 issue areas. Active from 2024 to 2025.
$660K
Total Spend
2
Years Active
1
Firms Hired
7
Lobbyists Deployed
3
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2024 | $290K |
| 2025 | $370K |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: MED, Health Issues, Government Issues
- •Issues impacting development of immunotherapies and optimizing use of mRNA technology.
- •Educated policymakers on BioNTech's federally funded research and development activities.
Related Analysis
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
DOGE vs. the Lobbying Machine
Government efficiency meets the lobbying industrial complex.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.